 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - AKCEA THERAPEUTICS Inc (AKCA)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-03-23 Sale | 2020-03-25 4:44 pm | AKCEA THERAPEUTICS Inc | AKCA | Patterson Joshua F. General Counsel | 335 | $11.76 | $3,938 | 14,614 (Direct) | View |
| 2020-03-23 Sale | 2020-03-25 4:43 pm | AKCEA THERAPEUTICS Inc | AKCA | Jenne Kyle Chief Commercial Officer | 779 | $11.75 | $9,153 | 52,732 (Direct) | View |
| 2020-03-23 Sale | 2020-03-25 4:42 pm | AKCEA THERAPEUTICS Inc | AKCA | O'Dea Louis Chief Medical Officer | 3,198 | $11.75 | $37,579 | 61,602 (Direct) | View |
| 2020-03-23 Sale | 2020-03-25 4:41 pm | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 9,417 | $11.75 | $110,649 | 245,783 (Direct) | View |
| 2019-07-15 Sale | 2019-07-17 4:52 pm | AKCEA THERAPEUTICS Inc | AKCA | Boyce Sarah President | 1,819 | $23.52 | $42,783 | 19,888 (Direct) | View |
| 2019-04-05 Sale | 2019-04-09 7:00 pm | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 50,000 | $31.71 | $1,585,718 | 2,880 (Direct) | View |
| 2019-04-05 Sale | 2019-04-09 6:59 pm | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 31,787 | $32.11 | $1,020,780 | 0 (Direct) | View |
| 2019-03-06 Sale | 2019-03-07 5:20 pm | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 18,386 | $32.14 | $590,856 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-03-19 Option Award | 2020-03-31 8:41 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 60,000 | $0 | 120,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-31 8:41 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 120,000 | $12.76 | 120,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:35 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Howarth Alex G. COO | 16,800 | $0 | 34,200 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:35 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | Howarth Alex G. COO | 34,200 | $12.76 | 34,200 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:34 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Jenne Kyle Chief Commercial Officer | 16,800 | $0 | 34,200 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:34 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | Jenne Kyle Chief Commercial Officer | 34,200 | $12.76 | 34,200 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:32 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | O'Dea Louis Chief Medical Officer | 16,800 | $0 | 34,200 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:32 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | O'Dea Louis Chief Medical Officer | 34,200 | $12.76 | 34,200 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:29 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Patterson Joshua F. General Counsel | 3,780 | $0 | 7,500 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:29 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | Patterson Joshua F. General Counsel | 7,500 | $12.76 | 7,500 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:22 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 55,200 | $0 | 200,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:22 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 109,800 | $12.76 | 200,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:22 pm | N/A 2030-03-18 | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 200,000 | $12.76 | 200,000 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-13 4:47 pm | N/A 2030-02-11 | AKCEA THERAPEUTICS Inc | AKCA | Salzman Amber Director | 53,000 | $17.94 | 53,000 (Direct) | View |
| 2020-01-15 Option Award | 2020-01-16 6:05 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | O'Dea Louis Chief Medical Officer | 28,000 | $0 | 48,000 (Direct) | View |
| 2020-01-15 Option Award | 2020-01-16 6:03 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | MacLean Michael F CFO | 28,000 | $0 | 48,000 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 5:23 pm | N/A 2030-01-01 | AKCEA THERAPEUTICS Inc | AKCA | O'Dea Louis Chief Medical Officer | 57,000 | $16.99 | 57,000 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 5:21 pm | N/A 2030-01-01 | AKCEA THERAPEUTICS Inc | AKCA | MacLean Michael F CFO | 57,000 | $16.99 | 57,000 (Direct) | View |
| 2019-12-17 Other | 2019-12-19 4:32 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | IONIS PHARMACEUTICALS INC 10% Owner | 6,873,344 | $0 | 77,094,680 (Direct) | View |
| 2019-12-13 Option Award | 2019-12-16 4:35 pm | N/A 2029-12-12 | AKCEA THERAPEUTICS Inc | AKCA | Yanni Barbara Director | 53,000 | $19.3 | 53,000 (Direct) | View |
| 2019-12-02 Option Award | 2019-12-04 4:08 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Howarth Alex G. COO | 50,000 | $0 | 300,000 (Direct) | View |
| 2019-12-02 Option Award | 2019-12-04 4:08 pm | N/A 2029-12-01 | AKCEA THERAPEUTICS Inc | AKCA | Howarth Alex G. COO | 300,000 | $17.94 | 300,000 (Direct) | View |
| 2019-10-21 Option Award | 2019-10-23 4:21 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Jenne Kyle Chief Commercial Officer | 25,000 | $0 | 50,000 (Direct) | View |
| 2019-10-21 Option Award | 2019-10-23 4:21 pm | N/A 2029-10-20 | AKCEA THERAPEUTICS Inc | AKCA | Jenne Kyle Chief Commercial Officer | 50,000 | $18.94 | 50,000 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-30 9:26 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 302,250 | $6.48 | 17,607 (Direct) | View |
| 2019-09-26 Tax Withholding | 2019-09-30 9:26 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 185,122 | $16.64 | 17,607 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-30 9:26 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 83,952 | $6.48 | 17,607 (Direct) | View |
| 2019-09-26 Tax Withholding | 2019-09-30 9:26 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 52,973 | $16.64 | 17,607 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-30 9:26 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 35,230 | $12.21 | 17,607 (Direct) | View |
| 2019-09-26 Tax Withholding | 2019-09-30 9:26 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 30,016 | $16.64 | 17,607 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-30 9:26 pm | N/A 2025-12-15 | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 302,250 | $6.48 | 17,607 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-30 9:26 pm | N/A 2026-02-16 | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 83,952 | $6.48 | 17,607 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-30 9:26 pm | N/A 2027-06-04 | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 35,230 | $12.21 | 17,607 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-30 5:52 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 1,711,079 | $6.48 | 102,740 (Direct) | View |
| 2019-09-26 Tax Withholding | 2019-09-30 5:52 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 1,113,492 | $16.64 | 102,740 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-30 5:52 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 145,303 | $6.48 | 102,740 (Direct) | View |
| 2019-09-26 Tax Withholding | 2019-09-30 5:52 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 95,156 | $16.64 | 102,740 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-30 5:52 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 205,479 | $12.21 | 102,740 (Direct) | View |
| 2019-09-26 Tax Withholding | 2019-09-30 5:52 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 175,064 | $16.64 | 102,740 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-30 5:52 pm | N/A 2025-12-15 | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 1,711,079 | $6.48 | 102,740 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-30 5:52 pm | N/A 2026-02-16 | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 145,303 | $6.48 | 102,740 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-30 5:52 pm | N/A 2027-06-04 | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 205,479 | $12.21 | 102,740 (Direct) | View |
| 2019-09-19 Option Award | 2019-09-23 7:22 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | O'Dea Louis Chief Medical Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-09-19 Option Award | 2019-09-23 5:24 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | MacLean Michael F CFO | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-09-19 Option Award | 2019-09-23 5:22 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 200,000 | $0 | 400,000 (Direct) | View |
| 2019-09-19 Option Award | 2019-09-23 5:22 pm | N/A 2029-09-18 | AKCEA THERAPEUTICS Inc | AKCA | McDevitt Damien CEO | 400,000 | $22.46 | 400,000 (Direct) | View |
| 2019-09-20 Option Award | 2019-09-23 5:12 pm | N/A 2029-09-19 | AKCEA THERAPEUTICS Inc | AKCA | YANG MICHAEL J. Director | 53,000 | $22.46 | 53,000 (Direct) | View |
| 2019-09-20 Option Award | 2019-09-23 4:35 pm | N/A 2029-09-19 | AKCEA THERAPEUTICS Inc | AKCA | KLEIN JOSEPH III Director | 53,000 | $22.46 | 53,000 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-03 4:31 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Boyce Sarah President | 813 | $20.04 | 21,707 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-03 4:28 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 430 | $20.04 | 3,310 (Direct) | View |
| 2019-06-14 Option Award | 2019-06-18 4:46 pm | N/A 2029-06-13 | AKCEA THERAPEUTICS Inc | AKCA | MOSCICKI RICHARD A Director | 26,400 | $22.74 | 26,400 (Direct) | View |
| 2019-06-14 Option Award | 2019-06-18 4:42 pm | N/A 2029-06-13 | AKCEA THERAPEUTICS Inc | AKCA | PARSHALL B LYNNE Director | 26,400 | $22.74 | 26,400 (Direct) | View |
| 2019-06-14 Option Award | 2019-06-18 4:38 pm | N/A 2029-06-13 | AKCEA THERAPEUTICS Inc | AKCA | Hochberg Elaine Director | 26,400 | $22.74 | 26,400 (Direct) | View |
| 2019-06-14 Option Award | 2019-06-18 4:35 pm | N/A 2029-06-13 | AKCEA THERAPEUTICS Inc | AKCA | SMITH SANDFORD D Director | 26,400 | $22.74 | 26,400 (Direct) | View |
| 2019-06-14 Option Award | 2019-06-18 4:31 pm | N/A 2029-06-13 | AKCEA THERAPEUTICS Inc | AKCA | FITZGERALD EDWARD M Director | 26,400 | $22.74 | 26,400 (Direct) | View |
| 2019-06-14 Option Award | 2019-06-18 4:28 pm | N/A 2029-06-13 | AKCEA THERAPEUTICS Inc | AKCA | GABRIELI CHRISTOPHER Director | 26,400 | $22.74 | 26,400 (Direct) | View |
| 2019-04-05 Exercise | 2019-04-09 7:00 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 30,000 | $6.48 | 2,880 (Direct) | View |
| 2019-04-05 Exercise | 2019-04-09 7:00 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 20,000 | $6.48 | 2,880 (Direct) | View |
| 2019-04-05 Exercise | 2019-04-09 7:00 pm | N/A 2025-12-15 | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 30,000 | $6.48 | 2,880 (Direct) | View |
| 2019-04-05 Exercise | 2019-04-09 7:00 pm | N/A 2025-12-15 | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 20,000 | $6.48 | 2,880 (Direct) | View |
| 2019-04-05 Exercise | 2019-04-09 6:59 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 30,000 | $6.48 | 0 (Direct) | View |
| 2019-04-05 Exercise | 2019-04-09 6:59 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 1,787 | $6.48 | 0 (Direct) | View |
| 2019-04-05 Exercise | 2019-04-09 6:59 pm | N/A 2025-12-15 | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 30,000 | $6.48 | 0 (Direct) | View |
| 2019-04-05 Exercise | 2019-04-09 6:59 pm | N/A 2025-12-15 | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 1,787 | $6.48 | 0 (Direct) | View |
| 2019-03-29 Other | 2019-04-02 4:20 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | IONIS PHARMACEUTICALS INC 10% Owner | 2,837,373 | $0 | 70,221,336 (Direct) | View |
| 2019-03-06 Exercise | 2019-03-07 5:20 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 18,386 | $6.48 | 0 (Direct) | View |
| 2019-03-06 Exercise | 2019-03-07 5:20 pm | N/A 2025-12-15 | AKCEA THERAPEUTICS Inc | AKCA | Soteropoulos Paula CEO | 18,386 | $6.48 | 0 (Direct) | View |
| 2019-01-02 Other | 2019-01-04 5:33 pm | N/A N/A | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 493 | $21.51 | 150,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-04 5:33 pm | N/A 2029-01-01 | AKCEA THERAPEUTICS Inc | AKCA | Goldberg Jeff Marc COO | 150,000 | $30.73 | 150,000 (Direct) | View |